Overview

Pilot Study of Bazedoxifene Plus Conjugated Estrogen on Imaging and Blood Biomarkers

Status:
Not yet recruiting
Trial end date:
2023-12-31
Target enrollment:
Participant gender:
Summary
Pilot study to test feasibility of 6 months of bazedoxifene (BZA) plus conjugated estrogens (CE) to modulate breast MRI parameters.
Phase:
Early Phase 1
Details
Lead Sponsor:
Carol Fabian, MD
Treatments:
Bazedoxifene
Estrogens
Estrogens, Conjugated (USP)